Intracellular Replication Inhibitory Effects of Tea Tree Oil on Vesicular Stomatitis Virus and Anti-inflammatory Activities in Vero Cells

Intracellular Replication Inhibitory Effects of Tea Tree Oil on Vesicular Stomatitis Virus and Anti-inflammatory Activities in Vero Cells

Viral disease management has been proven difficult, and there are no broadly licensed vaccines or therapeutics. Vesicular stomatitis virus (VSV) is an active pathogen of wild ungulates and livestock; its infection frequently caused irreversible vesicles on the tongue or other positions, leading to e...

Full description

Bibliographic Details
Main Authors:	Qi Shao, Junjie Huang, Jingui Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-11-01
Series:	Frontiers in Veterinary Science
Subjects:	tea tree oil vesicular stomatitis virus inflammatory cytokines antivirus effect viral replication
Online Access:	https://www.frontiersin.org/articles/10.3389/fvets.2021.759812/full

Similar Items

Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice
by: Jung-Eun Park, et al.
Published: (2021-12-01)

Examination of vesicular stomatitis virus-induced morphology changes in individual Vero cells by QMod microscopy
by: Isabel Scholz, et al.
Published: (2020-06-01)

First case report of vesicular stomatitis in the State of Paraíba, Brazil
by: Inácio José Clementino, et al.
Published: (2014-10-01)

Untargeted Lipidomics of Vesicular Stomatitis Virus-Infected Cells and Viral Particles
by: Katherine E. Havranek, et al.
Published: (2021-12-01)

Molecular Tracking of the Origin of Vesicular Stomatitis Outbreaks in 2004 and 2018, Ecuador
by: David Vasco-Julio, et al.
Published: (2023-02-01)

Assessment of Single‐Cycle M‐Protein Mutated Vesicular Stomatitis Virus as a Safe and Immunogenic Mucosal Vaccine Platform for SARS‐CoV‐2 Immunogen Delivery
by: En Zhang, et al.
Published: (2024-12-01)

Enterovirus vesicular stomatitis with exanthema: Epidemiological Features and Vaccination
by: Yu. S. Sytaya, et al.
Published: (2022-07-01)

Tamoxifen Protects from Vesicular Stomatitis Virus Infection
by: Lamin B. Cham, et al.
Published: (2019-09-01)

Interrogating Genomes and Geography to Unravel Multiyear Vesicular Stomatitis Epizootics
by: John M. Humphreys, et al.
Published: (2024-07-01)

The Methyltransferase Region of Vesicular Stomatitis Virus L Polymerase Is a Target Site for Functional Intramolecular Insertion
by: Emmanuel Heilmann, et al.
Published: (2019-10-01)

Oncolytic Vesicular Stomatitis Virus: Optimisation Strategies for Anti-Cancer Therapies
by: Margarita Zinovieva, et al.
Published: (2024-10-01)

Review of Vesicular Stomatitis in the United States with Focus on 2019 and 2020 Outbreaks
by: Angela Pelzel-McCluskey, et al.
Published: (2021-08-01)

Two Point Mutations in the Glycoprotein of SFTSV Enhance the Propagation Recombinant Vesicular Stomatitis Virus Vectors at Assembly Step
by: Qiang Hu, et al.
Published: (2023-03-01)

Evolution and expansion dynamics of a vector‐borne virus: 2004–2006 vesicular stomatitis outbreak in the western USA
by: Rachel Palinski, et al.
Published: (2021-10-01)

Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector
by: Guodong Liu, et al.
Published: (2021-08-01)

Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy
by: Suman Bishnoi, et al.
Published: (2018-02-01)

Full Genomic Sequencing of Vesicular Stomatitis Virus Isolates from the 2004–2006 US Outbreaks Reveals Associations of Viral Genetics to Environmental Variables
by: Rachel Palinski, et al.
Published: (2020-06-01)

γ-Aminobutyric acid promotes vesicular stomatitis virus infection in mouse macrophages
by: ZHAO Lu, LIU Yang
Published: (2023-06-01)

Producing Vesicular Stomatitis Virus G (VSVG) Protein and Assessment of its Cytotoxic Activity against Breast Cancer Cells
by: Fereshteh Ghandehari, et al.
Published: (2015-05-01)

Vesicular Stomatitis Virus Transmission Dynamics Within Its Endemic Range in Chiapas, Mexico
by: Lawrence H. Zhou, et al.
Published: (2024-11-01)

Immunovirotherapy Based on Recombinant Vesicular Stomatitis Virus: Where Are We?
by: Yuguo Zhang, et al.
Published: (2022-06-01)

Protective Efficacy of Lyophilized Vesicular Stomatitis Virus–Based Vaccines in Animal Model
by: Abd’jeleel Salawudeen, et al.
Published: (2024-05-01)

Modeling the 2014–2015 Vesicular Stomatitis Outbreak in the United States Using an SEIR-SEI Approach
by: John M. Humphreys, et al.
Published: (2024-08-01)

Detection of buffaloes (Bubalus bubalis) seroreactive for vesicular stomatitis virus in the state of Paraíba, Northeastern Brazil
by: Camila de Sousa Bezerra, et al.
Published: (2019-10-01)

Increased Virulence of an Epidemic Strain of Vesicular Stomatitis Virus Is Associated With Interference of the Innate Response in Pigs
by: Lauro Velazquez-Salinas, et al.
Published: (2018-08-01)

Assessment of the ability of V920 recombinant vesicular stomatitis-Zaire ebolavirus vaccine to replicate in relevant arthropod cell cultures and vector species
by: Nicholas A. Bergren, et al.
Published: (2018-04-01)

Recombinant adenovirus expressing vesicular stomatitis virus G proteins induce both humoral and cell-mediated immune responses in mice and goats
by: Xiaojuan Xue, et al.
Published: (2021-01-01)

Vesicular Stomatitis Virus: Insights into Pathogenesis, Immune Evasion, and Technological Innovations in Oncolytic and Vaccine Development
by: Mohamed Mustaf Ahmed, et al.
Published: (2024-12-01)

Efficacy and Immunogenicity of a Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine in Cynomolgus Macaques
by: Vidyleison N. Camargos, et al.
Published: (2024-07-01)

A Natural Botanical Product, Resveratrol, Effectively Suppresses Vesicular Stomatitis Virus Infection In Vitro
by: Shih-Chao Lin, et al.
Published: (2021-06-01)

Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
by: Andrea Marzi, et al.
Published: (2015-02-01)

A single-point mutation in the rubella virus E1 glycoprotein promotes rescue of recombinant vesicular stomatitis virus
by: Pratyush Kumar Das, et al.
Published: (2024-03-01)

Host predilection and transmissibility of vesicular stomatitis New Jersey virus strains in domestic cattle (<it>Bos taurus</it>) and swine (<it>Sus scrofa</it>)
by: Smith Paul F, et al.
Published: (2012-10-01)

Comparison of Endemic and Epidemic Vesicular Stomatitis Virus Lineages in <i>Culicoides sonorensis</i> Midges
by: Paula Rozo-Lopez, et al.
Published: (2022-06-01)

RIG‐I‐mediated innate immune signaling in tumors reduces the therapeutic effect of oncolytic vesicular stomatitis virus
by: Pengfei Zhang, et al.
Published: (2023-01-01)

Vesicular Stomatitis Virus Transmission: A Comparison of Incriminated Vectors
by: Paula Rozo-Lopez, et al.
Published: (2018-12-01)

A Single Amino Acid Substitution in the Matrix Protein (M51R) of Vesicular Stomatitis New Jersey Virus Impairs Replication in Cultured Porcine Macrophages and Results in Significant Attenuation in Pigs
by: Lauro Velazquez-Salinas, et al.
Published: (2020-05-01)

Diversity in responses to oncolytic Lassa-vesicular stomatitis virus in patient-derived glioblastoma cells
by: Teddy E. Kim, et al.
Published: (2021-09-01)

Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus
by: Dakota W. Goad, et al.
Published: (2022-03-01)

An HPLC-SEC-based rapid quantification method for vesicular stomatitis virus particles to facilitate process development
by: Adrian Schimek, et al.
Published: (2024-06-01)